Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Friedlaender

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reviews|August 21, 2023
Novel targets for immune-checkpoint inhibition in cancerMaxime Borgeaud, Jose Sandoval, Michel Obeid, et al.
Cancer Treatment Reviews|January 22, 2026
Personalized cancer vaccines and their integration with standard of care modalitiesTiia Snäkä, Alex Friedlaender, Michele Graciotti, et al.
Nature Reviews. Clinical Oncology|October 6, 2021
Author Correction: EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatmentAlex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Journal of Hematology & Oncology|October 26, 2022
Drugging KRAS: current perspectives and state-of-art reviewKaushal Parikh, Giuseppe Banna, Stephen V Liu, et al.
Nature Reviews. Clinical Oncology|September 25, 2021
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatmentAlex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Urology|December 9, 2019
Prostate Cancer Nonascitic Peritoneal Carcinomatosis After Robot-assisted Laparoscopic Radical Prostatectomy: 3 Case Reports and Review of the LiteratureVerane Achard, Gilles Achard, Alex Friedlaender, et al.
Oncology Reviews|August 13, 2020
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigmGiuseppe Luigi Banna, Ornella Cantale, Melissa Bersanelli, et al.
Med (New York, N.Y.)|January 29, 2026
Precision oncology in rare tumors: Have the orphans been adopted?Hiba Mechahougui, Alex Friedlaender, Kıvanç Görgülü, et al.
Clinical Genitourinary Cancer|April 14, 2021
Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With ImmunotherapyFrancesco Rundo, Melissa Bersanelli, Valeria Urzia, et al.
Current Oncology Reports|November 4, 2021
A New Generation of Vaccines in the Age of ImmunotherapyAlfredo Addeo, Alex Friedlaender, Elisa Giovannetti, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reviews|August 21, 2023
Novel targets for immune-checkpoint inhibition in cancerMaxime Borgeaud, Jose Sandoval, Michel Obeid, et al.
Cancer Treatment Reviews|January 22, 2026
Personalized cancer vaccines and their integration with standard of care modalitiesTiia Snäkä, Alex Friedlaender, Michele Graciotti, et al.
Nature Reviews. Clinical Oncology|October 6, 2021
Author Correction: EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatmentAlex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Journal of Hematology & Oncology|October 26, 2022
Drugging KRAS: current perspectives and state-of-art reviewKaushal Parikh, Giuseppe Banna, Stephen V Liu, et al.
Nature Reviews. Clinical Oncology|September 25, 2021
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatmentAlex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Urology|December 9, 2019
Prostate Cancer Nonascitic Peritoneal Carcinomatosis After Robot-assisted Laparoscopic Radical Prostatectomy: 3 Case Reports and Review of the LiteratureVerane Achard, Gilles Achard, Alex Friedlaender, et al.
Oncology Reviews|August 13, 2020
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigmGiuseppe Luigi Banna, Ornella Cantale, Melissa Bersanelli, et al.
Med (New York, N.Y.)|January 29, 2026
Precision oncology in rare tumors: Have the orphans been adopted?Hiba Mechahougui, Alex Friedlaender, Kıvanç Görgülü, et al.
Clinical Genitourinary Cancer|April 14, 2021
Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With ImmunotherapyFrancesco Rundo, Melissa Bersanelli, Valeria Urzia, et al.
Current Oncology Reports|November 4, 2021
A New Generation of Vaccines in the Age of ImmunotherapyAlfredo Addeo, Alex Friedlaender, Elisa Giovannetti, et al.
Pageof 11